Bellevue Asset Management (Switzerland)’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q4	$8.85M	Sell	130,869 -22,586	-15%	-$1.53M	1.35%	21
2015 Q3	$8.2M	Buy	153,455 +31,322	+26%	+$1.67M	1.34%	21
2015 Q2	$7.69M	Sell	122,133 -27,202	-18%	-$1.71M	1.07%	28
2015 Q1	$7.18M	Buy	+149,335	New	+$7.18M	1%	35